PIK3CA and metastatic neoplasm: On the other side, PIK3CA mutations seemed to activate AKT, as expression was higher among mutated primary and metastatic tumors (Supplementary Table S5 and Supplementary Fig. S3c), similar to observations made in colorectal cancer58.